法制日报
Is Science Venture Dalian the Same as Beijing Kexing?
What is Science Venture Dalian?
Science Venture Dalian is a vaccine manufacturer based in Dalian, China. The company specializes in the production of inactivated vaccines for a range of infectious diseases, including COVID-19, influenza, and hepatitis B. Science Venture Dalian is a subsidiary of Kexing Biopharmaceuticals, a leading biotech company in China.
What is Beijing Kexing?
Beijing Kexing Biopharmaceuticals, also known as Sinovac, is a biotech company located in Beijing, China. The company specializes in the research, development, and production of vaccines for multiple infectious diseases, including COVID-19, hepatitis A and B, and influenza. Beijing Kexing is one of the leading vaccine manufacturers in China.
Are Science Venture Dalian and Beijing Kexing the same?
While Science Venture Dalian is a subsidiary of Beijing Kexing Biopharmaceuticals, the two companies operate independently. Both companies specialize in vaccine production, but they may use different processes and facilities. Additionally, Science Venture Dalian focuses on the production of inactivated vaccines, whereas Beijing Kexing produces both inactivated and live attenuated vaccines.
What is the difference between Science Venture Dalian's vaccine and Beijing Kexing's vaccine?
Science Venture Dalian has developed an inactivated COVID-19 vaccine that has received emergency use approval in China. The vaccine, known as Anhui Zhifei Longcom, requires two doses within a four-week interval. Beijing Kexing Biopharmaceuticals, on the other hand, has developed the CoronaVac vaccine, a two-dose inactivated vaccine that has been widely used in multiple countries. The CoronaVac vaccine has shown efficacy rates ranging from 50-90% in different clinical trials.
Conclusion
While Science Venture Dalian and Beijing Kexing Biopharmaceuticals are both vaccine manufacturers based in China, they are not the same company. Science Venture Dalian is a subsidiary of Beijing Kexing, but operates independently and focuses on the production of inactivated vaccines. Both companies have developed COVID-19 vaccines that have been approved for emergency use, but their vaccines may differ in their effectiveness.
